Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00481637 · ClinicalTrials.gov registry record
Study to Evaluate Immune Responses in Neurologically Normal Cancer Patients
A clinical trial, sponsored by Rockefeller University.
- Completed
- Registry status
- 33
- Enrollment target
NCT00481637 is a clinical trial that has completed, run by Rockefeller University. The registered enrollment target is 33 participants.
The verdict
NCT00481637 has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to study whether immune cells capable of killing tumors that express proteins associated with paraneoplastic neurologic syndrome (PNS) can be found in small cell lung cancer and ovarian cancer patients. The presence of these cells may play a role in tumor immunity in these patients. The protocol involves neurological examinations and collection of blood.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 1998-03 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00481637
The ClinicalTrials.gov registry entry for NCT00481637 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00481637 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00481637 about?
NCT00481637 is a clinical study titled "Study to Evaluate Immune Responses in Neurologically Normal Cancer Patients". The purpose of this study is to study whether immune cells capable of killing tumors that express proteins associated with paraneoplastic neurologic syndrome (PNS) can be found in small cell lung cancer and ovarian cancer patients. The presence of these cells may play a role in tumor immunity in the...
What is the current status of trial NCT00481637?
This trial is currently completed. The enrollment target is 33 participants. The study started on 1998-03. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT00481637?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.